Forum Financial Management, LP Edwards Lifesciences Corp Transaction History

Forum Financial Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$81.41 - $94.33 $48,357 - $56,032	594 Added 24.08%	3,061 $288,000
Q1 2023 Apr 19, 2023	BUY	$74.26 - $84.51 $183,199 - $208,486	2,467 New	2,467 $204,000
Q3 2022 Nov 07, 2022	BUY	$82.37 - $107.29 $26,770 - $34,869	325 Added 13.68%	2,700 $223,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $205,437 - $304,641	2,375 New	2,375 $226,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $262,648 - $330,603	-2,576 Closed	0 $0
Q4 2021 Feb 18, 2022	BUY	$106.37 - $130.68 $274,009 - $336,631	2,576 New	2,576 $334,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

Stay updated on Forum Financial Management, LP with notifications on news.